Famotidine Tablet
Product Images NDC 43602-511

4 FDA label images from Ascent Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 43602-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascent Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cl-10 mg (Cl 10 mg 300s)

Cl-10 mg (Cl  10 mg 300s)
Label of Famotidine Tablets USP 10 mg oral tablets by Ascent Pharmaceuticals, Inc., labeled as an acid reducer that prevents and relieves heartburn due to acid indigestion. The container holds 300 tablets. The label includes warnings, directions for use, inactive ingredients, and a caution not to use if the inner seal is broken or missing.*
FDA Label Image

Cl-20 mg (Cl 20 mg 300s)

Cl-20 mg (Cl  20 mg 300s)
FAMOTIDINE 20 mg tablets label from Ascent Pharmaceuticals, Inc. Described as an acid reducer for heartburn and acid indigestion relief. The label highlights maximum strength, package count of 300 tablets, and instructions to take just one tablet. It includes warnings, directions, inactive ingredients, and manufacturer information.*
FDA Label Image

Carton-10 mg (Carton 10 mg 300s)

Carton-10 mg (Carton  10 mg  300s)
Packaging label for Famotidine Tablets USP, 10 mg, an oral acid reducer by Ascent Pharmaceuticals, Inc. The label indicates it contains 300 tablets and specifies the product as original strength. The box design includes a yellow human outline with red highlighting on the stomach, along with various drug facts and directions for use.*
FDA Label Image

Carton-20 mg (Carton 20 mg 300s)

Carton-20 mg (Carton  20 mg  300s)
Packaging label for Famotidine Tablets USP, 20 mg, maximum strength acid reducer. The label shows 300 tablets in the package and states the product is OTC, to be taken orally. It includes the labeler, Ascent Pharmaceuticals, Inc., Central Islip, NY. The label features a yellow highlighted "Maximum Strength" warning and an illustration of a human figure with red highlighting on the stomach area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.